FDA Inspection 1229962 — George Timothy Kelly. M.D.

George Timothy Kelly. M.D. — FEI 3015772033

The FDA completed an inspection of George Timothy Kelly. M.D. on February 15, 2024 in Las Vegas, NV. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 15, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Las Vegas, NV (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752621 CFR 312.62(a)Accountability records
756021 CFR 312.60FD-1572, protocol compliance